TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome
about
Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall.Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers.Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution.Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.Systematic identification of Ctr9 regulome in ERα-positive breast cancerTargeting Transcription Factors in CancerAP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation.Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.A comprehensive comparison of tools for differential ChIP-seq analysis.Inducible super-enhancers are organized based on canonical signal-specific transcription factor binding elements.Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome.Chromatin Scanning by Dynamic Binding of Pioneer Factors.The Estrogen Receptor α-Cistrome Beyond Breast Cancer.Reciprocal Feedback Between miR-181a and E2/ERα in Myometrium Enhances Inflammation Leading to Labor.PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity.Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone.Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.DNA Sequence Constraints Define Functionally Active Steroid Nuclear Receptor Binding Sites in Chromatin.Transcription pausing regulates mouse embryonic stem cell differentiation.Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.Catalytic-Independent Functions of PARP-1 Determine Sox2 Pioneer Activity at Intractable Genomic Loci.From discovery of the CHOP axis and targeting ClpP to the identification of additional axes of the UPRmt driven by the estrogen receptor and SIRT3.Chromatin reprogramming in breast cancer.The IL-4/STAT6/PPARγ signaling axis is driving the expansion of the RXR heterodimer cistrome, providing complex ligand responsiveness in macrophages.ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.Dynamic evolution of regulatory element ensembles in primate CD4+ T cells.Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
P2860
Q30490853-BBA4AB2A-8157-414A-B032-5EA479CA9D05Q31132786-98910F9B-F942-4BCC-8C72-978A8582AEDDQ33587378-89DEFE75-DE37-4ACE-9732-24D281592D21Q36082731-04A423C9-519F-45F1-B097-98B854D3A78CQ36187708-5057BA58-E4B9-4D9E-8E22-35AE64C8ABF4Q36347511-BA0649C3-CE13-4DE0-B79B-9C7BC267849DQ36650302-228980DC-95E3-4FE2-A0D0-DFAF750CFC62Q37376167-2BFB5F1E-909F-44B0-8C20-8BE40238FA62Q38432603-6B0A5BC0-40D6-4092-BEA8-C5ACD64E17C4Q38695905-6BE7B92D-31F5-4001-949C-27E054F453B4Q38725396-BE0F8DF3-39E9-4E95-9976-D1C19E3FAB21Q38743542-141CA1C8-D6A9-4607-B379-EFAD860CF16BQ38853105-9E74980C-A84F-4ADA-AB98-0150F85BDC58Q38917972-7DF26E5F-6B5E-491A-B583-11BEE057B1C5Q41646660-940C3185-3FDE-44E9-AB62-BD0E05E0D2A5Q42803577-3CF08000-02B4-4711-88EC-B38547ACF51BQ47142116-9FD75FDE-E600-4AC4-95A1-1E35683DB0FCQ47157413-754B87FD-7A69-4F17-A500-7449C6A93110Q47699717-9CDF2663-166B-4B8E-A84A-FA920A94C357Q47817891-18F3BE01-0B76-4064-94A7-0A9C413AB6C1Q49391608-DEB2C6B2-C61E-48DE-A943-81B9CDF51B86Q49607235-BA265606-E003-4949-BD92-757AF4977C75Q50207620-6FEC6190-9503-43DC-B30C-A6CDA17862FEQ51803792-B57D4A15-478A-4ACF-8549-B69227B3F49EQ52310380-B9859C05-3085-4D09-8301-42AC98C10858Q52366978-32160AC4-1E26-492D-9812-4C68744289F0Q53699376-0FB3105D-C9D8-4861-8575-65725F58DAA5Q54963126-0CF0938E-CA8B-4DE3-BE7E-A1B4C9D94E79Q57106904-FBF6B8E7-60DE-465D-860F-C1ACCF4A3747
P2860
TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
TNFα signaling exposes latent ...... east cancer cell transcriptome
@ast
TNFα signaling exposes latent ...... east cancer cell transcriptome
@en
type
label
TNFα signaling exposes latent ...... east cancer cell transcriptome
@ast
TNFα signaling exposes latent ...... east cancer cell transcriptome
@en
prefLabel
TNFα signaling exposes latent ...... east cancer cell transcriptome
@ast
TNFα signaling exposes latent ...... east cancer cell transcriptome
@en
P2860
P1433
P1476
TNFα signaling exposes latent ...... east cancer cell transcriptome
@en
P2093
Anusha Nagari
W Lee Kraus
P2860
P356
10.1016/J.MOLCEL.2015.02.001
P577
2015-03-05T00:00:00Z